Next-Generation Sequencing (NGS) is generating tomorrow’s cures. Illumina (Solexa) sequencing, Roche 452 sequencing, Ion torrent (Proton/PGM) sequencing, and SOLiD sequencing are revolutionizing the study of genomics and molecular biology. Next-generation sequencing is enabling precision medicine for an individual sufferer by connecting potential biomarkers to access clinical results. This is digital healthcare.
The breakthrough
The 1st DNA sequencing began in the early 1970’s, but this was slow and extremely expensive which prevented scaling for the benefit of population health. By the period of 1990’s many new methods for DNA sequencing were developed and by the year 2000, these procedures were executed commercially by DNA sequencers (a scientific instrument used to automate the DNA sequencing process). Next-generation sequencing is high-throughput DNA sequencing, which sequences millions or billions of DNA strands in parallel, reducing the need for the fragment-cloning methods utilized in Sanger genome sequencing – making better the speed critical for patient usability.
No comments:
Post a Comment